PHARMA

Quarterly rpt on consolidated results for the financial period ended 30/9/2008

PHARMANIAGA BERHAD

Financial Year End

31/12/2008
Quarter3
Quarterly report for the financial period ended30/09/2008
The figureshave not been audited

Attachments

Pharma 3Q2008.pdf
311 KB

SUMMARY OF KEY FINANCIAL INFORMATION
30/09/2008

 
INDIVIDUAL PERIOD
CUMULATIVE PERIOD
CURRENT YEAR QUARTER
PRECEDING YEAR
CORRESPONDING
QUARTER
CURRENT YEAR TO DATE
PRECEDING YEAR
CORRESPONDING
PERIOD
30/09/2008
30/09/2007
30/09/2008
30/09/2007
RM'000
RM'000
RM'000
RM'000
1Revenue
314,288
334,700
977,403
891,166
2Profit/(loss) before tax
17,641
31,915
66,103
54,326
3Profit/(loss) for the period
11,048
21,561
43,487
35,271
4Profit/(loss) attributable to ordinary equity holders of the parent
10,590
21,302
42,242
34,011
5Basic earnings/(loss) per share (sen)
9.90
19.92
39.49
31.80
6Proposed/Declared dividend per share (sen)
0.00
0.00
18.00
15.00
 
AS AT END OF CURRENT QUARTER
AS AT PRECEDING FINANCIAL YEAR END
7
Net assets per share attributable to ordinary equity holders of the parent (RM)
3.5000
3.2700

Note: For full text of the above announcement, please access KLSE Web site at www.klse.com.my


Remarks :
No interim ordinary dividend has been declared for the financial period ended 30 September 2008 (2007:nil)

A final tax exempt dividend of 18.0% (2006:15.0%) on 106,963,188 (2006:106,963,188) ordinary shares of RM 1.00 each in respect of the previous financial year amounting to RM 19,253,374 (2006:16,044,478) was approved by shareholders on 22 May 2008 and paid on 2 July 2008.


Announcement Info

Company NamePHARMANIAGA BERHAD  
Stock Name PHARMA    
Date Announced24 Nov 2008  
CategoryFinancial Results
Reference NoPB-081124-69854